NHERF1 and pancreatic neoplasm: However, such allelic loss is infrequent in other tumor types; LOH at the NHERF1 locus occurred in fewer than 10% of colorectal and pancreatic cancer lines, suggesting that NHERF1 is specifically targeted during breast tumorigenesis [15].